Pharma Focus Asia


Pharma white papers on contemporary issues, technologies, research, etc. are presented in this section to enable the readers with rich information and knowledge. This section provides white papers related to all the spheres of the pharma industry.

A Comprehensive Guide to Responsible AI for Life Sciences

From latestage clinical development through commercialization life sciences teams depend on highquality evidence from a vast array of sources to discover diagnose and improve treatments and health outcomes

Introduction to EU Regulatory Affairs

In the European Union a network of approximately regulatory authorities from the European Economic Area countries the European Commission and European Medicines Agency form the basis of the European regulatory system

Six Reasons Why Direct Patient Support is a ‘must have’ for Your Clinical Trials

With a growing and ageing global population an efficient and continuous drug development pipeline is crucial in the biopharmaceutical industrys ongoing mission to keep people well

Pharmacovigilance Challenges in Early Phase Clinical Trials

Early phase clinical trials have their own unique challenges as they play a vital role in drug development During early trials we aim to evaluate the safety tolerability

The Reckoning of Antimicrobial Resistance, A new biological frontier

The life sciences sector is permanently evolving but a moment of reckoning has arriveda moment that compels us at Cavenagh Health to address a real global threat that resonates beyond

Roadmap to Biomarker Discovery: Innovations, Opportunities, and Breakthroughs

Biomarkers are indicators of homeostasis disease states or pharmacological interventions An ideal biomarker must be bina present or absent quantifiable in tissues cells body fluids or in simple physiological parameters

How Prancer RTSM® Enables Complex Studies - The Complex Study is Here to Stay

Clinical researchers are becoming much more creative in how they explore possible treatments They are leveraging more adaptive trials where phases can be combined or skipped based on positive results or where the protocol is amended to explore new treatments or disease states within the same trial

The Need For Adaptive Trial Design In Oncology Studies

Trial research needs to account for increased complexity and competition when recruiting patients in cancer studies Patients and oncologists have more choices than ever for the placement of qualified study participants Not only are treatments more specialised but the industry

Navigating IDMP Compliance in the Pharmaceutical Industry

In an era of increasing regulatory demands the pharmaceutical industry faces the challenge of adhering to the Identification of Medicinal Products IDMP standards This whitepaper provides guidance to understanding and implementing IDMP compliance outlining the benefits and potential challenges and offering practical solutions We at AdEx Partners as Trusted Leaders in Business Transformation off...

RNA Therapeutics

An exploration of a rapidly growing field in the biotech industry with the potential to revolutionise the treatment of a wide range of diseases

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference